ArticleRSC advances2026
A low-cost liquid crystal display (LCD)-printed microfluidic device: fabrication and application in the biodegradation of petroleum hydrocarbons in petroleum refinery sludge.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liquid crystal display (LCD) printing is evolving into a ground-breaking technique in the biological domain, demonstrating the benefits of fabricating low-cost, high-resolution, complex geometry in bulk compared to the time-consuming and labour-intensive lithography techniques. However, the exploration of 3D-printed microfluidic devices for bioremediation and biofilm formation remains underrepresented in the current literature. This article describes the validation of a cost-effective LCD-printed microfluidic device that was employed as a biofilm-assisted carrier for the remediation of petroleum hydrocarbons in refinery sludge. Our technology surpasses current bioremediation approaches by providing a degrading surface that differs from standard methods relying solely on particulate carriers. A novel microbial consortium comprising four hydrocarbon-degrading strains (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.